AVAILABLE DOSSIERS. Product name Pharmaceutical form Strength Reference Therapeutic class

Similar documents
CONTACT POLPHARMA GROUP POLPHARMA B2B

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY

CENTRAL NERVOUS SYSTEM CARDIOVASCULAR SYSTEM DIGESTIVE SYSTEM BONE DISEASE UROLOGICS ANTIBACTERIAL ANTIVIRALS ANTIMYCOTICS ANTIDEPRESSIVES

Table 1 Details of products supplied and the correlation coefficient of each of these products against its reference.

Anti Diabetic. BE Reference product. Diamicron Gliclazide MR Tablets 60 mg (Servier, France) HCl XR Tablets 500 mg (BMS, US)

ASEBP and ARTA TARP Drugs and Reference Price by Categories

SOLID DOSAGE FORMULATIONS

formulations Product List- row

Innovative Products Available. OTC Products Available

J Jubilant Pharma Group, catering to Dosage

Daiichi Sankyo, Inc. (DSI)

MEDICINES CONTROL COUNCIL

Drugs Categories. 4. Which suffix do erectile dysfunction generic drug names often end with?

Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)

Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada,

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5

Table updated 15 th February Sodium valporate 15 th February Ramipril & Felodipine 15 th February 2019

II. Angiotensin Receptor Blockers (ARBs) Drug Class Review

Prescription Drugs. Medicare & Medicaid Briefings National Health Policy Forum February 22, Jim Hahn Congressional Research Service

in patients with diabetes, nephropathy and/or chronic kidney disease Summary of recommendations July 2017

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6

ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR

2. Review of literature: 2.1 General review on methods of simultaneous determination of hypertensive drugs.

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

ANTIPAF Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial

Hypertension, Hyperlipidemia and Obesity. Mi-CCSI

Boston University Expert Review Meeting on the Evaluation of Novartis Access

A.K. Gitt, F. Towae, C. Juenger, A. Papp, R. Zahn, U. Zeymer, J. Senges For the STAR-Study-Group Herzzentrum Ludwigshafen, Germany

PBS Growth. The changing composition of the PBS. PBS Top 10 drugs in transition. Shifting sands for industry as generic volume soars

Cardiovascular Risk Reduction in Diabetic Mellitus. Presenter: Dr. Martin N. Wanyoike MB.CHB., M. Med.(internal med) Physician / Cardiologist

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

Drug Regimen Optimization

Table updated 26 th February Salbutamol 26 th February Lofepramine hydrochloride 22 nd February Zoledronic acid 21 st February 2019

nephropathy and/or chronic kidney disease Summary of recommendations

THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series

LONG TERM CARE MEDICATIONS MANAGEMENT INITIATIVE JULY Prepared by the Long-Term Care Medications Management Working Group

Evidence grades for the recommendations

Updates to the Alberta Drug Benefit List. Effective November 1, 2018

Simvastatin 40 mg equivalent

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015

Thiazide or Thiazide Like? Choosing Wisely Academic Detailing Conference Digby Pines October 12-14

Angiotensin II Receptor Antagonists (ARBs), Renin Inhibitors, and Combinations Step Therapy Program Summary

National Medicines Management Programme

Amlodipine/olmesartan (Azor ) is indicated for the treatment of hypertension, alone or in combination with other antihypertensive medications.

TRICARE Uniform Formulary. Pre-Authorization Requirements

STEP THERAPY ALGORITHMS PUP Select Formulary

Pharmacy Costs: Can I Make a Difference?

Industry Relationships and Institutional Affiliations

2017 Step Therapy Criteria

Daiichi Sankyo s U.S. Products Liability Litigation Settlement Program Moves Forward; More than 97 Percent of Eligible Litigants and Claimants Opt In

THE ART OF DRUG SYNTHESIS

Product Catalog. Summer * Image not to scale

Systemic and inhaled fluoroquinolones: risk of aortic aneurysm and dissection

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

John Ansell President, John Ansell Consultancy Thame, UK

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)

CHAPTER ONE: EXECUTIVE SUMMARY

ADHD STIMULANTS-S(SHC)

Kern Pharma Portfolio 2014

WORK PLAN FOR THE EFFICACY WORKING PARTY (EWP) CHAIRPERSON: Barbara van Zwieten-Boot

PORTFOLIO MADE WITH CARE. FDF Generics Chlorhexidine API

The RealiseAF registry:

Stroke and Headache Headache and Stroke

Supplementary Appendix

Demand and Price Dynamics within the Pharmaceutical Benefits Scheme

PBS PRICE INCREASES - AUGUST 2014 SCHEDULE

The Global SYMPLICITY Registry: Safety and Effectiveness of Renal Artery Denervation In Real World Patients With Uncontrolled Hypertension

Updates to the Alberta Drug Benefit List. Effective September 1, 2018

ATYPICAL ANTIPSYCHOTICS

Information for Vermont Prescribers of Prescription Drugs

Innovator brand name (for fixed combination products only) Proposed EU HBD. Active substance name (INN)

Lisinopril losartan conversion dose

Information in these slides is used with permission from St. Mary s Cardiac Rehab

CMI Marketplace 2015 (List of Covered Drugs)

DT Description Price Category Price change

PULMONARY ARTERIAL HYPERTENSION AGENTS

Medicines Procurement South West

2017 UnitedHealthcare Services, Inc.

Medications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy

Information for Vermont Prescribers of Prescription Drugs

SecureBlue Formulary 2016 Master Negative Changes from 2015 to 2016

Disclosure of Relationships

OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE 20/5/12.5 MG National Drug Code Directory

Nclex para la Enfermera Hispana

MEDICINES CONTROL COUNCIL

SOLID DOSAGE FORMULATIONS

GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 July 2011 No. 4761

Orodispersible tablets & Tablets

ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

Leitner Christian. Best Selling Drugs

Angiotensin II Receptor Blockers Dosage in hypertensive patients as well as patients with left ventricular hypertrophy

Transcription:

DOSSIER LIST

AVAILABLE DOSSIERS Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM Esomeprazole sodium Omeprazole sodium injection / 40 mg Nexium / AstraZeneca Antiulcerant 40 mg Losec / Astra Zeneca Antiulcerant Orlistat Capsules 60 mg - 120 mg Alli / GSK - Xenical / Roche Obesity treatment Pantoprazole sodium sesquihydrate injection / 40 mg Pantozol / Altana Antiulcerant ANTI-INFECTIVES FOR SYSTEMIC USE Aciclovir Tablets 200 mg - 400 mg - 800 mg Zovirax / Glaxo Antiviral for systemic Ciprofloxacin hydrochloride Clarithromycin Levofloxacin hemihydrate Levofloxacin hemihydrate 250 mg - 500 mg Ciproxin / Bayer 500 mg Klacid IV / Abbot 250 mg - 500 mg Tavanic / Aventis Solution for 250 mg / 50ml - 500 mg / 100ml Tavanic / Aventis Linezolid 600 mg Zyvox / Pfizer Linezolid Solution for 2 mg/ml Zyvox / Pfizer Voriconazole 50 mg - 200 mg Vfend / Pfizer Antifungal for systemic Voriconazole 200 mg Vfend / Pfizer Antifungal for systemic ANTINEOPLASTIC & IMMUNOMODULATING AGENTS Bicalutamide 50 mg - 150 mg Casodex / AstraZeneca Cytostatic hormone antagonist (Anti-androgens) Imatinib 100 mg - 200 mg - 400 mg Glivec / Novartis Antineoplastic CARDIOVASCULAR SYSTEM Bosentan * NEW! 62.5 mg - 125 mg Tracleer / Actelion Pulmonary arterial hypertension (PAH) treatment Candesartan cilexetil Tablets 4 mg - 8 mg - 16 mg - 32 mg Atacand / AstraZeneca Angiotensin-II antagonist

AVAILABLE DOSSIERS Product name Pharmaceutical form Strength Reference Therapeutic class CARDIOVASCULAR SYSTEM Hydrochlorothiazide * Tablets 12.5 mg - 25 mg --- Diuretic Indapamide Prolonged-release tablets 1.5 mg Natrilix / Servier Diuretic Metoprolol succinate Prolonged-release tablets 23.75 mg - 47.5 mg - 95 mg - 190 mg Beloc-Zoc / AstraZeneca Beta blocking Olmesartan medoxomil 10 mg - 20 mg - 40 mg Benicar / Daiichi Sankyo Angiotensin-II antagonist Olmesartan medoxomil + Hydrochlorothiazide 20 mg + 12.5 mg - 20 mg + 25 mg - 40 mg + 12.5 mg - 40 mg + 25 mg Olmetec Plus / Daiichi Sankyo Angiotensin-II antagonist & diuretic combination Rosuvastatin calcium * 5 mg - 10 mg - 20 mg - 40 mg Crestor / AstraZeneca Cholesterol & triglyceride regulator Simvastatin 10 mg - 20 mg - 40 mg - 80 mg Zocor / MSD Cholesterol & triglyceride regulator Valsartan 80 mg - 160 mg Diovan / Novartis Angiotensin-II antagonist DERMATOLOGICALS Dimetindene Gel 1 mg/g Fenistil / Novartis Topical antipruritic GENITO-URINARY SYSTEM & SEX HORMONES Vardenafil hydrochloride * NEW! 5 mg - 10 mg - 20 mg Levitra / Bayer Erectile dysfunction treatment MUSCULO-SKELETAL SYSTEM Alendronic acid * Tablets 70 mg Fosamax / Merck Bone calcium regulator NERVOUS SYSTEM Aripiprazole * Tablets 5 mg - 10 mg - 15 mg - 30 mg Abilify / Otsuka Ltd / BMS Antipsychotic Atomoxetine Capsules 5 mg - 10 mg - 18 mg - 25 mg - 40 mg - 60 mg - 80 mg - 100 mg Strattera / Eli Lilly ADHD treatment Citalopram hydrobromide 10 mg - 20 mg - 30 mg - 40 mg Seropram / Lundbeck Antidepressant

We offer: High level of customer service Excellent products with CTD dossier meeting EU requirements Regulatory knowledge and expertise Full support in developing registration strategies to meet the customer s needs Execution and support of registration procedures upon customer s request QA service and Pharmacovigilance service (PSUR) Intellectual property expertise Professional and competent team skilled in project management techniques Partnership in a win-win strategy CONTACT POLPHARMA GROUP Pharmaceutical Works Pelplińska 19 83-200 Starogard Gdański Poland Phone: +48 58 563 16 00 Fax: +48 58 562 23 53 www.polpharma.pl POLPHARMA B2B STRATEGIC PARTNER, FARMAPROJECTS Santa Eulàlia 240-242 08902 L Hospitalet de Llobregat Barcelona (Spain) Phone: +34 93 508 0500 Fax. +34 93 508 0501 e-mail: salesb2b@polpharma.com www.polpharmab2b.com